Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Clinical characteristics including cardiovascular and metabolic risk factors in adolescents with psoriasis

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Position statement: The need for EU legislation to require disclosure and labelling of the composition of medical devices

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Metronidazole for Hidradenitis Suppurativa: future potential treatment applications

    Publikation: Bidrag til tidsskriftLetterpeer review

  3. Obesity as a risk factor for psoriasis

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  1. Safety of the combined use of methotrexate and acitretin in a dermatology hospital setting

    Publikation: Bidrag til tidsskriftLetterpeer review

  2. Memory T helper cells identify patients with nickel, cobalt, and chromium metal allergy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Association between vascular inflammation and inflammation in adipose tissue, spleen, and bone marrow in patients with psoriasis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

BACKGROUND: Clinical studies on psoriasis in adolescents have mainly been performed in patients with severe psoriasis. Population-based studies of clinical characteristics and risk factors for later cardiovascular and metabolic disease in children and adolescents are lacking.

OBJECTIVES: To examine the clinical characteristics of adolescents with psoriasis nested in a general population cohort. Furthermore, to investigate cardiovascular and metabolic risk factors in the adolescents with psoriasis compared to parentally predisposed and non-predisposed adolescents without psoriasis from the same birth cohort.

METHODS: We identified adolescents with and without psoriasis using a nationwide general population birth cohort in Denmark. A clinical examination included skin inspection and scoring of psoriasis severity, completion of a questionnaire on psoriasis and comorbidities, physical measurements, and blood sampling. Participants also completed self-administered questionnaires on quality of life and mental health.

RESULTS: We included 81 adolescents with psoriasis and 234 controls (110 with genetic predisposition for psoriasis and 124 without predisposition). Median age was 15.6 (13.5-18.5) years, and in those with active psoriasis, median Psoriasis Area and Severity Index score was 1.2 (0.1-11.4). The scalp was the most common site of psoriasis, both at debut and at time of examination. Diaper rash in infancy was more frequent in the psoriasis group. No significant differences regarding quality of life, anxiety and depression were found. More adolescents with psoriasis were obese (8.6% vs. 1.7%, P = 0.008), and physical measures of abdominal obesity were also significantly higher. HbA1c was significantly higher (31.55 vs. 30.81 mmol/mol, P = 0.048), while no differences were found for blood pressure, lipids or high-sensitivity C-reactive protein. In a subgroup analysis, this was evident in the non-predisposed psoriasis-free controls only.

CONCLUSIONS: Overall, adolescents with psoriasis from this general population had mild disease. Still, early markers of cardiovascular and metabolic disease were elevated.

OriginalsprogEngelsk
TidsskriftJournal of the European Academy of Dermatology and Venereology : JEADV
Vol/bind34
Udgave nummer7
Sider (fra-til)1516-1523
Antal sider8
ISSN0926-9959
DOI
StatusUdgivet - jul. 2020

Bibliografisk note

© 2020 European Academy of Dermatology and Venereology.

ID: 61761710